Company / Operating Cash Flow
Artivion Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$39.9M
FY2025
5-year range
$12.4M / $39.9M
FY2021-FY2025
Trend
+79.3%
vs FY2024
Sector context
#128 of 164
Health Care
What the data says
Artivion's operating cash flow of $40M is lower than 78% of companies in the Health Care sector (FY2025). Operating Cash Flow has increased for 3 consecutive years, from $12M in FY2022 to $40M in FY2025.
Based on SEC 10-K filings.
$40M in FY2025 with a 5-year CAGR of +32.2%.
Improved from $19M to $40M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- +47.7%
- 5-Year CAGR
- +32.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 164This company $39.9M Sector average $1.0B
▼
-96.2% below sector average
Key checks
Key Insights
- Artivion's operating cash flow has grown for 3 consecutive years.
- 5-year CAGR of +32.2%, indicating consistent growth.
- In FY2025, operating cash flow increased 79.3% year-over-year.
- Ranks #128 out of 164 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 1.21 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $39.9M | +79.3% |
| FY2024 | $22.2M | +18.1% |
| FY2023 | $18.8M | +52.2% |
| FY2022 | $12.4M | -21.8% |
| FY2021 | $15.8M | +60.2% |
| FY2020 | $9.9M | -8.5% |
| FY2019 | $10.8M | -45.2% |
| FY2018 | $19.7M | +72.3% |
| FY2017 | $11.4M | +40.9% |
| FY2016 | $8.1M | -51.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026